Works in Cancer Medicine, 2025, Vol 14, Issue 7


Results: 55
    1

    Issue Information.

    Published in:
    Cancer Medicine, 2025, v. 14, n. 7, p. 1, doi. 10.1002/cam4.7264
    Publication type:
    Article
    2
    3
    4

    Circulating Tumour DNA in Patients With EGFR‐Mutated Non‐Small‐Cell Lung Cancer and Early Disease Progression After First‐Line Osimertinib Treatment: The ELUCIDATOR Multicentre Prospective Observational Study.

    Published in:
    Cancer Medicine, 2025, v. 14, n. 7, p. 1, doi. 10.1002/cam4.70861
    By:
    • Tamiya, Akihiro;
    • Mizumori, Yasuyuki;
    • Osuga, Mitsuo;
    • Isa, Shun‐ichi;
    • Taniguchi, Yoshihiko;
    • Nakamura, Keiichi;
    • Harada, Daijiro;
    • Shinohara, Tsutomu;
    • Yanai, Hidetoshi;
    • Nakatomi, Katsumi;
    • Oki, Masahide;
    • Mori, Masahide;
    • Kuwako, Tomohito;
    • Yamazaki, Koji;
    • Tamura, Atsuhisa;
    • Ando, Masahiko;
    • Koh, Yasuhiro
    Publication type:
    Article
    5
    6
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: A Phase II Study.

    Published in:
    Cancer Medicine, 2025, v. 14, n. 7, p. 1, doi. 10.1002/cam4.70835
    By:
    • Mukherjee, Sarbajit;
    • Fujiwara, Yu;
    • Fountzilas, Christos;
    • Pattnaik, Harsha;
    • Chatley, Sarah;
    • Vadehra, Deepak;
    • Kukar, Moshim;
    • Attwood, Kristopher;
    • George, Anthony;
    • Advani, Shailesh;
    • Yu, Han;
    • Catalfamo, Kayla;
    • Brown, Alyson;
    • Spickard, Erik;
    • Fungtammasan, Arkarachai;
    • George, Sagila;
    • Liao, Chih‐Yi;
    • Iyer, Renuka;
    • Hatoum, Hassan
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian Cancer.

    Published in:
    Cancer Medicine, 2025, v. 14, n. 7, p. 1, doi. 10.1002/cam4.70804
    By:
    • Kato, Shu;
    • Baba, Kaede;
    • Mamishin, Kanako;
    • Uematsu, Mao;
    • Shimura, Mai;
    • Hirota, Akira;
    • Fukuda, Misao;
    • Takahashi, Nobuyuki;
    • Nakao, Takehiro;
    • Nakajima, Hiromichi;
    • Funasaka, Chikako;
    • Kondoh, Chihiro;
    • Harano, Kenichi;
    • Naito, Yoichi;
    • Matsubara, Nobuaki;
    • Hosono, Ako;
    • Kawasaki, Toshikatsu;
    • Mukohara, Toru
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Quality‐Adjusted Time Without Symptoms of Disease or Toxicity (Q‐TWiST) in Patients With Newly Diagnosed Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia: A Comparison of Ponatinib Versus Imatinib.

    Published in:
    Cancer Medicine, 2025, v. 14, n. 7, p. 1, doi. 10.1002/cam4.70780
    By:
    • Ashaye, Ajibade;
    • Shi, Ling;
    • Aldoss, Ibrahim;
    • Montesinos, Pau;
    • Vachhani, Pankit;
    • Rocha, Vanderson;
    • Papayannidis, Cristina;
    • Leonard, Jessica T.;
    • Baer, Maria R.;
    • Ribera, Jose‐Maria;
    • McCloskey, James;
    • Wang, Jianxiang;
    • Rane, Deepali;
    • Guo, Shien
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50